InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Discover the complete record of transactions filed by Zweifach Sanford S. Director active across 2 companies, notably Carisma Therapeutics Inc.. Aggregated, 2 reports have been published. Activity tracked since 29 July 2026. The latest transaction was filed on 29 July 2026 (Attribution). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations